BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05633602-completion@plaintrial.com
DTSTAMP:20261027T170734Z
DTSTART;VALUE=DATE:20280315
SUMMARY:Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage
  IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy\, Prag
 matica-Lung Study — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05633602
URL:https://plaintrial.com/trial/NCT05633602
END:VEVENT
END:VCALENDAR